When it comes to treating patients suffering from heart failure, which is typically defined as a heart whose ...
Pharmaceuticals
This channel includes news and new technology innovations for cardiovascular pharmaceutics. This includes antiplatelet agents, anticoagulation drugs, INR testing, NOAC, OAC, IV administered drugs such as Heprin, and dual antiplatelet therapy.
May 1, 2007 — Cardiome Pharma Corp. says this week it has received exclusive worldwide rights to Eli Lilly & Co.'s ...
April 26, 2007 — Cardiologist Lee A. Surkin, M.D., FAAC, is set to launch a new line of cardiac nutritional supplements ...
April 26, 2007 — Bristol-Myers Squibb Co. and Pfizer Inc. have announced a worldwide collaboration to develop and ...
April 25, 2007 — CV Therapeutics Inc. has announced that data from the MERLIN TIMI-36 study will be published in this ...
April 25, 2007 — Bristol-Myers Squibb will host a groundbreaking ceremony May 2 for its new biologics facility in Devens ...
April 19, 2007 — Schering-Plough Corp. has announced plans to initiate two global Phase III large-scale clinical ...
April 19, 2007 — Following Tuesday’s seizing of all implantable medical devices from Shelhigh Inc., Union, NJ, by FDA ...
April 16, 2007 — LegalView.com has added a database of up-to-date information about FDA-approved drugs, which ...
April 9, 2007 — The FDA has approved Abbott's new coated Niaspan (niacin extended-release tablets) for boosting HDL ...
Pfizer says the FDA has approved the company’s Lipitor (atorvastatin calcium) Tablets to reduce the risk of ...
March 22, 2007 — Pfizer says the FDA has approved the company’s Lipitor (atorvastatin calcium) Tablets to reduce the ...
Thyroid hormone has multiple effects on the cardiovascular system. These include increased cardiac contractility ...
March 9, 2007 — Pfizer has announced that the FDA has approved Lipitor (atorvastatin calcium) Tablets to reduce the risk ...
Feb. 6, 2007 — The FDA has issued an approval letter for GlaxoSmithKline’s once-a-day anticoagulant, Arixtra ...